Compare AbCellera Biologics Inc (ABCL) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Realty Income Corp — how do they compare? AbCellera Biologics Inc trades at $8.96 (market cap $2.99B), while Realty Income Corp trades at $61.94 (market cap $58.56B). The key difference: Realty Income Corp is far larger — about 19.6× AbCellera Biologics Inc's market cap, and Realty Income Corp pays a 5.25% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | O | |
|---|---|---|
Market Cap | $2.99B | $58.56B |
Sector | Health | Real Estate |
52-Week High | $9.76 | $67.56 |
52-Week Low | $2.78 | $55.93 |
Enterprise Value | $2.58B | $89.19B |
Dividend Yield | — | 5.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
